Although pathological hallmarks of β amyloid (Aβ) deposition and tau neurofibrillary tangles (NFTs) are AD characteristics, it is known that tau burden is more strongly associated with cognitive dysfunction and neurodegeneration than Aβ accumulation [1, 3, 4]. The gene discussed is MAPT; the disease is Alzheimer disease.